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Abstract
Background: The role of Mycoplasma hominis and M. genitalium in urogenital tract infections remains unknown.
Furthermore these mollicutes present a complex relationship with the host immune response. The role of inflammatory
cytokines in infections also makes them good candidates to investigate bacterial vaginosis and mycoplasma genital
infections. Therefore, the aim of this study was to detect the above-mentioned mollicutes by quantitative Polymerase
Chain Reaction (qPCR) methodologies in vaginal swabs and dosage of cytokines.
Methods: Vaginal swabs and peripheral blood were collected from 302 women, including healthy individuals. The
molecular findings were correlated with some individual behavioral variables, clinical and demographic characteristics,
presence of other important microorganisms in vaginal swabs, and levels of interleukin (IL)-1β and IL-6.
Results: M. hominis and M. genitalium were detected in 31.8% and 28.1% of samples, respectively. The qPCR results
were associated with clinical signs and symptoms of the infections studied. The frequency of Trichomonas vaginalis,
Gardnerella vaginalis, Neisseria gonorrhoeae and Chlamydia trachomatis was 3.0%, 21.5%, 42.4%, and 1.7% respectively.
Increased levels of IL-1β were associated with the presence of M. hominis and signs and/or symptoms of the genital
infection of women studied.
Conclusion: IL-1β production was associated with the detection of M. hominis by qPCR. The sexual behavior of women
studied was associated with the detection of mycoplasma and other agents of genital infections.
Keywords: Mycoplasma genitalium, Mycoplasma hominis, urogenital infection
Background
Sexually Transmitted Infections (STIs) occur worldwide
and are an important public health problem. In develop-
ing countries STIs are among the five most frequent
causes for seeking health services. The World Health
Organization (WHO) estimates that about 340 million
new cases of STIs occur each year. In Brazil, ten to
twelve million new cases are reported each year [1,2].
Depending of the infectious agent, the STI is usually
expressed in a skin lesion, secretion, vaginal discharge,
wart, or blister. Mollicutes are included in STIs, but they
are also found in healthy individuals. However five de-
cades ago some mollicutes were considered infectious
agents of the human urogenital tract [3]. This inconsist-
ent history has made it challenging to clarify the role of
these bacteria. The host-pathogen relationship is a com-
plex and variable subject, but some interactions that
have been studied have helped better understand this
important relationship [4].
M. hominis is associated with non-gonococcal ureth-
ritis (NGU), bacterial vaginosis (BV) and post-birth fever
[5], and rarely with bacteremia, arthritis [6], peritonitis [7]
and meningitis [8]. In turn, M. genitalium was identified
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as a possible etiological agent of NGU and non-chlamydial
urethritis [9]. This species has been detected in cervical
samples from patients with salpingitis and acute endomet-
ritis [10]. Furthermore, M. genitalium has been strongly
associated with cervicitis [11]. In women, an increase of
vaginal discharge may be reported as well as dysuria, but
the infection may be asymptomatic [12].
The mollicutes mentioned above also present a com-
plex relationship in the host immune response [13]. It is
well established that inflammatory cytokines play a
critical role in regulating the response to infections. In
fact these cytokine levels were associated with the pres-
ence of mycoplasmas. This renders them good candi-
dates to be studied in the development of BV and
mycoplasmal infections [14].
Although most genital mycoplasmas are cultured in a
specific culture media, M. genitalium is quite fastidious.
PCR assays for detecting this mollicute in clinical sam-
ples help better understand its incidence and distribu-
tion. In recent years, PCR became a readily-available and
reliable method for detecting mollicutes in the human
genital tract [15]. Therefore, the aim of this study was to
detect M. hominis and M. genitalium and measure pro-
inflammatory cytokines in a group of women with or
without genital signs and/or symptoms of genital infec-
tion. The women studied live in Vitória da Conquista, a
city located in the state of Bahia, Brazil.
Results
M. hominis and M. genitalium were detected in 31.8%
(96/302) and 28.1% (85/302), respectively in the women
studied. The load of M. hominis and M. genitalium in the
swab samples was measured by quantitative Polymerase
Chain Reaction (qPCR). M. genitalium load ranged from 1
to ≥ 103 copies/μL, while for M. hominis, it ranged from 1
to ≥ 104 copies/μL. The mean amount of both species in
swab samples was higher in women with signs of infec-
tion or symptoms than in the control group. However,
no statistical difference was observed using the Mann–
Whitney test.
The clinical samples were also tested by conventional
PCR for other microorganisms. T. vaginalis, N. gonor-
rhoeae, G. vaginalis and C. trachomatis were found in
3.0%, 21.5%, 42.4%, and 1.7% of samples, respectively.
Table 1 summarizes the co-infections detected with myco-
plasmas and other species with gynecological importance.
The M. hominis and M genitalium detected by qPCR
using univariate analysis, showed that women under age 25
presented a higher risk for M. hominis infection (p = 0.034)
[see Additional file 1], while those living in rural regions
(p < 0.001), who sought consultation due to symptom-
atic reasons (p < 0.017), had one or more sexual partners
in the last three months (p = 0.039), reported pruritus
(p = 0.007) and presented vaginal discharge (p = 0. 006),
presented a higher risk of infection to M. genitalium
[see Additional file 1].
Using multivariate analysis, the risk for infection by
M. hominis is associated with clinical visits due to symp-
toms, educational years (<12 years), age at first inter-
course (≤15 years), sexually active, age (<25 years) and
race/color (black/brown/indigenous) [see Additional
file 1]. For M. genitalium infection, a highest risk was
associated with region of residence, number of sexual
partners in the past three months, having signs and/or
symptoms suggestive of STI, and discharge and itchy
genital site [see Additional file 1].
Cytokine levels were compared between women
qPCR-positive and negative for M. hominis. Women
with M. hominis DNA presented a mean of interleukin
(IL)-1β levels higher than those without M. hominis
(p = 0.047) (Figure 1A). However, the IL-6 levels did
not present a statistical difference between infected
and non-infected women (p = 0.326) (Figure 1B). Fur-
thermore, a statistical difference was not observed for
IL-1β (p = 0.407) nor IL-6 levels (p = 0.332) (Figure 1C
and 1D) when comparing case and control groups
qPCR-positive for M. hominis.
Table 1 Co-infection of genital microorganisms in vaginal
samples of women from Vitória da Conquista, Brazil
Microorganisms n (%)
MG +MH 15 (4.97)
MG + GV 12 (3.97)
MG + CT 1 (0.33)
MG + NG 4 (1.32)
MG +MH + GV 6 (1.99)
MG +MH + NG 8 (2.65)
MG +MH + TV 1 (0.33)
MG + NG + GV 1 (0.33)
MG +MH + NG + GV 4 (1.32)
MG +MH + GV + TV 1 (0.33)
MH+ GV 21 (6.95)
MH+ NG 4 (1.32)
MH + TV 1 (0.33)
MH+ NG + GV 14 (4.63)
MH+ GV + CT 1 (0.33)
MH + TV + GV 1 (0.33)
MH + TV + NG + GV 1 (0.33)
GV + CT 2 (0.66)
NG + GV 17 (5.62)
Total number of women with coinfection 115 (38.08)
MG =Mycoplasma genitalium, MH =Mycoplasma hominis, GV = Gardnerella
vaginalis, NG = Neisseria gonorrhoeae, CT = Chlamydia trachomatis,
TV = Trichomonas vaginalis. N = 302 (absolute number of samples tested).
The main co-infections found are marked in bold.
Campos et al. BMC Infectious Diseases  (2015) 15:60 Page 2 of 8
Figure 1 Quantification of IL-1β and IL-6 (pg/mL) by ELISA in plasma samples. (A) Concentration of IL-1β (pg/mL) in the plasma of groups
of women qPCR positive and negative for M. hominis; (B) Concentration of IL-6 (pg/mL) in the plasma of groups of women qPCR positive and
negative for M. hominis (C) Concentration of IL-1β (pg/mL) in plasma of women M. hominis qPCR-positive from case and control groups (D)
Concentration of IL-6 (pg/mL) in plasma of women M. hominis qPCR-positive from case and control groups. (E) Concentration of IL-1β (pg/mL) in
the plasma of groups of women qPCR positive and negative for M. genitalium; (F) Concentration of IL-6 (pg/mL) in the plasma of groups of
women qPCR positive and negative for M. genitalium (G) Concentration of IL-1β (pg/mL) in plasma of women M. genitalium qPCR-positive from
case and control groups (H) Concentration of IL-6 (pg/mL) in plasma of women M. genitalium qPCR-positive from case and control groups. Standard
deviation and mean are indicated by solid lines in the graph. Statistical analysis by Mann Whitney. *p < 0.05; **p < 0.01.
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Women with M. genitalium, otherwise presented IL-6
levels lower than the qPCR-negative group for this mol-
licute (p = 0.004) (Figure 1E). The IL-1β levels com-
pared between the same two groups of women did not
present a statistical difference (p = 0.833) (Figure 1F).
Comparing cytokine levels between case and control
groups qPCR-positive for M. genitalium also did not
show a statistical difference in levels of IL-1β (p = 0.747)
and IL-6 (p = 0.858) (Figure 1G and 1H).
Discussion
In the present study, the frequency of M. hominis in the
women studied was 31.8% using qPCR. There is still no
consensus regarding the role of detected M. hominis,
although M. hominis has been isolated from urogenital
infections. However, the presence of M. hominis (MH)
has been correlated with the development of pelvic in-
flammation, spontaneous abortions and infertility [16].
Despite the lack of statistical significance, the average
MH load was higher in women with signs and/or symp-
toms than without this condition. Probably the bacterial
load is closely related to the development of the disease.
Few studies have reported the detection of MH by qPCR.
Baczynska et al. [17] observed the presence of MH using
qPCR in only 2.4% of cervical samples of women attend-
ing fertility clinics in Denmark. According to the authors,
the results were similar when compared with culture
results. Likewise, Cunningham et al. [18] obtained positive
findings for MH using qPCR in 14% of genitourinary
samples (vaginal swabs and urine) in the United States.
Most studies focus on conventional PCR analysis [19]. In
southeastern Brazil, Rodrigues et al. [20], in a study of
cervical swabs of 224 women who attended three specific
women’s healthcare clinics, reported MH in 21.9% of
samples.
In the present study, we observed that first intercourse
before age 15, and age less than 25 were associated with
the risk of infection by MH. Similar results were re-
ported by Kataoka et al. [21] who analyzed 877 samples
of vaginal swabs in Japan and Verteramo et al. [22] who
analyzed the risk behavior of women infected with MH.
No association was observed for other STI markers. How-
ever, a study performed with 153 Greek women, reported
a strong association of MH with BV, urinary symptoms
(e.g. unexplained chronic voiding, dysuria and urethritis)
and active sexual activity [23]. Furthermore, other positive
associations were also reported in the literature such as
C. trachomatis co-infection [21], G. vaginalis, T. vaginalis
and U. urealyticum co-infections [24], abortion [22], use
of condoms, race or multiple sexual partners [24].
M. genitalium (MG) is recognized as an etiological
agent of NGU in men, while in women it is recognized
as an etiological agent of cervical inflammation, infertil-
ity and pelvic inflammatory disease. Prevalence of 28.1%
(85/302) was found in this study using qPCR. Normally
the prevalence in the population of MG is considered
low. Falk et al. [25], using urine and cervical samples of
women attending an STD clinic for women in Orebro,
Sweden, reported frequency of 6%. Walker et al. [26], in
a cohort study of 16 to 25 year old Australian women
recruited from primary healthcare clinics, also observed
a low frequency of MG (2.4%). In Brazil, Rodrigues et al.
[20] reported a frequency of only 0.9%. However, Casin
et al. [27] observed a high prevalence of MG in women
attending a sexually-transmitted-disease clinic in Paris.
In addition, MG was recovered more often from the
vaginal epithelial cells (39%) than from the cervix (21%).
Similar results in women attending sexually-transmitted-
disease clinics were also observed by Gaydos et al. [28]
and Mobley et al. [29] who reported a prevalence of 19.2%.
Furthermore, Mobley et al. [29] also detected a higher
prevalence of MG in vaginal samples. According to the
authors, this may reflect a minimal host immune response
to MG infection in the vaginal epithelium, and thus greater
bacterial survival in the vagina compared to the endocer-
vix, where the inflammatory response to MG by endocervi-
cal epithelial cells is more robust. Herein the load of MG
in the studied samples was also higher in symptomatic
than in asymptomatic women. However, there was no
significant statistical difference in both groups. Among
the women studied with signs and symptoms of STI,
32.2% were qPCR positive for MG; the relation between
these two events was statistically significant (p = 0.004)
(data not shown).
In the present study, several risk factors for myco-
plasmal infection were analyzed in studies using logis-
tic regression. The highest risk was associated with the
Brazilian region of residence, number of sexual part-
ners in the past three months, having signs and/or
symptoms suggestive of STI, including runny discharge
and itchy genital site. The risk of infection for MG
associated with the age of women is variable in the lit-
erature. Consistent with the present study, Huppert
et al. [30] and Kataoka et al. [21] also observed no relation
between the ages of women. No mention of positive asso-
ciation was observed between signs and symptoms and
MG infection in other studies. On the contrary, a negative
association with the symptom dysuria has been reported
[29]. In addition, the following risk factors have been
reported in the literature for MG urogenital infection in
women, including: a recent sexual contact [30], prema-
ture birth [31], number of sexual partners in the last
month, smoking, intimate hygiene with douche and
history of spontaneous abortion [32]. Coinfection with
C. trachomatis and T. vaginalis [31] were also reported
as risk factors for MG infection.
The detected frequencies for T. vaginalis, N. gonor-
rhoeae, G. vaginalis and C. trachomatis in women
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studied were 3.0%, 21.5%, 42.4%, and 1.7% respectively.
The difference in prevalence between the mycoplasmas
and the searched microorganisms and risk factors com-
pared with the literature could be related to the popula-
tion studied. Some authors confirm that the prevalence of
genital microorganisms is related to regional differences
[1,27,28,33-35]. However, explanations for these differ-
ences are not clear, are variable and require more study.
The women studied live in the Northeast region of Brazil,
which has a semi-arid climate, with high rates of poverty.
This population depends strictly on basic governmental
health services. At the time of collection of clinical mater-
ial, the healthcare service for women was not in service
for several months. We believe this factor associated with
lack of knowledge regarding prevention and treatment of
STIs may have contributed to this prevalence obtained.
In addition, approximately thirty-eight percent of women
showed colonization with more than one microorganism.
The most common coinfections were between M. hominis
and G. vaginalis (6.95%). These two microorganisms are
considered commensal of the genital tract [36]. Leli et al.
[37] observed that patients positive for M. hominis were
more frequently colonized by G. vaginalis. The coinfection
of G. vaginalis and N. gonorrheae (5.62%), M. genitalium
and M. hominis (4.97%), M. hominis, N. gonorrheae and
G. vaginalis (4.63%), and M. genitalium and G. vaginalis
(3.97%) also were observed. The coinfection among
genital microorganisms has been frequently reported
[20,26,28,29,38,39]. According Gaydos et al. [28], these
findings have important implications in the diagnosis
and treatment of genital infections. There are no treat-
ment guidelines for genital mycoplasmas in Brazil. The
antibiotics used are not standardized and may not be
effective in all cases of M. genitalium or M. hominis
infection.
The opportunistic role of mollicutes includes some
features of the innate immune response. In the present
study, a higher level of IL- 1β was observed in infected
women than in non-infected with MH, but no difference
was observed in IL-6 levels. In the literature, the pres-
ence of MH was associated with higher levels of vaginal
IL-1β, but not with vaginal interleukin-1 receptor antag-
onist (IL-1rα) levels nor intra-amniotic fluid levels of
IL-1β, IL-1rα and IL-6 [40]. According to Wasiela et al.
[41], vaginal levels of IL- 8 but not IL-1α, IL-1β or IL-6 are
higher in women with mycoplasma infection. Ryckman
et al. [14] observed that vaginal IL-1β, IL-6 and IL-8 levels
in pregnant were significantly higher in women with
any mycoplasma compared to those without. This may
be related to bacterial pathogen-associated molecular
pattern (PAMPS). Mollicutes possess a large number of
lipoproteins, termed lipid-associated membrane pro-
teins (LAMPs). Recognition of LAMPs by the innate
immune system can trigger the production of various
proinflammatory cytokines from manifold cells, a surface
component that causes inflammation [42-44]. Therefore it
is possible to conclude that the immune response to molli-
cutes is variable due the host and the antigenic mosaic
and variation of mollicutes. This may explain in part the
potential role of Mollicutes in mammals to be excellent
opportunistic microorganisms that modulate the immune
response differently.
Women infected with MG showed mean levels of IL-6
lower than the qPCR-negative group. These findings
may be explained by the low M. genitalium load, or per-
sistent infection. In fact, IL-6 is produced mainly in the
acute phase of inflammation in the vagina [45]. McGowin
et al. [46] found that MG induce IL-6 in human A2EN
and ShEN101 cells during acute secretion (48 h). However,
in a persistent infection lasting 36 days, a noted, but
insignificant level of IL-6 was detected. Furthermore,
the interleukin concentrations could be lower in plasma,
despite the presence of this microorganism.
Conclusions
This study also contributed to the epidemiological data of
STI in the chosen geographic region for local public health,
especially because most STIs in Brazil are not notifiable
diseases. Due to the complexity of vaginal microbiota and
limited understanding of its role in urogenital diseases, fur-
ther studies of mollicutes are needed to better understand
the role of these bacteria in the urogenital tract of women.
Methods
Women studied
This analytical cross-sectional study analyzed clinical
samples from Vitória da Conquista city, the third largest
city of Bahia State, in the northeast of Brazil. The
women included in the study attended a Brazilian public
health clinic, known as the ‘Unified Health System’. The
study population consisted of 302 women, ages ranging
from 14 to 78 years, and averaging 37 years. Clinical sam-
ples were obtained (vaginal swab and peripheral blood).
Each woman was asked a series of questions and their
answers were recorded. The exclusion criteria were preg-
nancy, HIV positive and with antimicrobial therapy in the
last 3 months. Clinical signs and symptoms, such as
discharge, itch, fetid odor and dysuria were considered.
Furthermore, information about sexual experience and
behavior were gathered in interviews with trained staff to
minimize information bias.
Ethics statement
The study protocol was approved by the Research Ethics
Committee of the Biomedical Science Institute of São
Paulo University (998/2012). Study subjects provided
written informed-consent before participating in the study
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Clinical samples
The samples were collected from May to July of 2011
and January of 2012. The swabs were rubbed on the
internal surface of vagina. The samples were stored at
4°C in 5 mL of transport media. Blood samples were
collected in two 5 mL tubes with and without Ethylene-
diamine tetracetic acid (EDTA) and the serum was
stored at −20°C for Enzyme Linked Immuno Sorbent
Assay (ELISA) assay. The vaginal samples were homoge-
nized and stored at −20°C for DNA extraction.
Quantitative PCR (qPCR)
Genomic DNA samples of vaginal swabs were obtained
according to the recommendations of Purelink™ Gen-
omic DNA Mini Kit (Invitrogen, São Paulo, SP, Brazil).
Real-time PCR was performed in duplicate for each sam-
ple. A protocol for DNA amplification was performed
with a TaqMan Probe for M. hominis [47] and M. genita-
lium [48]. For constructing DNA standards for absolute
quantitation, the mycoplasmas were first cultured in
2 ml at 37°C and expanded to a 50 ml of SP4 broth. In
a logarithmic growth phase (based in colorimetric
changes), the culture was centrifuged at 20,600 g for
30 minutes at 25°C. The DNA was extracted using a
PureLink™ Genomic DNA Mini Kit. The genomic DNA
copy number was then calculated by spectrophotometry
(NanoDrop ND-1000, Witec Ag, Littau, Switzerland).
Ten-Fold serial dilutions (107–10 copies/μl) of the
mycoplasma DNA standard were prepared and analyzed.
Differential conventional PCR was also performed to
detect G. vaginalis [49], T. vaginalis [50], N. gonorrhoeae
and C. trachomatis [51].
Cytokine quantification
An ELISA kit (Bioscience, San Diego, C. A., United
States) and high-absorption 96-well microplates were
used to quantify cytokines. After standardization of a
curve and volume sample, 100 μL of each serum was
used to quantify cytokines IL-1β and IL-6. The immu-
noenzymatic reactions were measured by ELISA with a
wavelength of 450 nm.
Statistical analysis
Clinical and epidemiological data obtained were ana-
lyzed using the SPSS 16.0 software (SPSS Inc., Chicago,
USA). The association between variables was compared
applying the chi-square Pearson test or Fisher’s exact
test. Statistical significance was considered p < 0.05 with
a 95% CI. Risk factors associated with infection were
evaluated by the Odds Ratio (OR) and univariate ana-
lysis. All variables with p < 0.10 were included in multi-
variate analysis using logistic regression. Multivariate
logistic regression was used to assess the independent
contribution of the variables associated with the detection
of microorganisms. For cytokine quantification data ana-
lysis, the GraphPad Prism program was used. The non-
parametric Mann–Whitney test was used when evaluating
two groups.
Additional file
Additional file 1: Univariate and multivariate analysis of possible
risk factors for Mycoplasma hominis and M. genitalium infections in
women from Vitória da Conquista, Brazil, 2011.
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